On Thursday, November 12, join healthcare policy professionals, medtech industry leaders, academic partners, and clinical professionals in the nation’s capital for InHealth’s Fifth Anniversary Summit on current challenges for health technology research.
Today’s focus on comparative effectiveness is setting a new course for clinical decision-making—but will the emphasis on clinical data leave policymakers shortchanged for the evidence they need to chart a course for healthcare reform?
This summit will explore realms of health technology research that can produce useful evidence for healthcare policymakers. In four dynamic sessions featuring leading health economists, regulators, healthcare delivery professionals, and patient advocates, the summit will examine the approaches and evidence needed to go beyond current, clinically focused research priorities.
Tomorrow’s healthcare payment models, delivery systems, and policy objectives will be shaped by the reform solutions now under discussion. Innovative technologies can add tremendous value to the goals of healthcare reform by improving patient outcomes, productivity, and quality of life. This summit will explore ways to better understand how rapidly advancing healthcare technologies are likely to contribute to the advancement of healthcare systems in the United States and around the world.
Robert J. Rubin, MD, Clinical Professor of Medicine, Georgetown University
Former Assistant Secretary of Health and Human Services and Assistant U.S. Surgeon General
Member, InHealth Board of Directors
Chair, InHealth Research Council
Session I: The Growing Need for Evidence 9:00–10:30
In the world of health systems design, evidence-based medicine is not the same as evidence-based policy—and each concept means different things to different stakeholders. The clinical data needed to guide patient care are rarely a match for the broader information needs of third-party payers, lawmakers, or regulators. In this session, researchers with specialties in clinical, economic, and policy issues examine how current research priorities are influencing health system designs as well as regulatory and reimbursement policy—with potentially unpredictable results for patient access to advanced medical technologies. Panelists discuss the information required by policymakers and regulators for sound reform of healthcare.
Naomi Aronson, PhD
Executive Director, Technology Evaluation Center
Director, Evidence-Based Practice Center
Blue Cross-Blue Shield Association
John F. P. Bridges, PhD
Department of Health Policy & Management
Johns Hopkins Bloomberg School of Public Health
J. Michael McGinnis, MD, MPP
Director, Evidence-Based Medicine Roundtable
Institute of Medicine
The National Academies
Session II: Shaping the Evidence 11:00–12:30
Because health technology studies influence clinical adoption, reimbursement policy, and a wide range of other issues, researchers often find themselves challenged to design rapid studies to serve the needs of many stakeholders, including clinicians, manufacturers, policymakers, regulators—and the broader public. In this session, experts look at the challenges faced by healthcare researchers in finding the proper balance among such disparate interests, the roles of such stakeholders, and how the public interest can be both served and protected. Presenters address the differences between clinically focused comparative effectiveness research (CER) and impact-focused research into socioeconomic effectiveness (RISE).
John E. Calfee, PhD
American Enterprise Institute
Gregory de Lissovoy, PhD, MPH
Senior Research Scientist
Center for Health Economics and Science Policy
Vice President of Health Technology
United BioSource Corp.
Bill Fox, JD
The National Center For Patient Interactive Research
University Science Center
Session III: Evidence in the Media 1:30–3:00
To build public understanding and shape better policy, health technology researchers need journalists and other members of the media who are willing to report their results. In this session, representatives of ‘old’ and ‘new’ media channels—including peer-reviewed publications—describe how their media report health technology studies to professional and public audiences, and explore ways to sustain public interest and avoid contextual confusion in the face of often-conflicting findings. Presenters discuss how to maximize policy utility when reporting technology-related research.
A. Mark Fendrick, MD
Professor, Internal Medicine, and Health Management and Policy
Center for Value Based Insurance Design
University of Michigan Medical Center
Co-Editor in Chief, American Journal of Managed Care
Medical Device Daily
John J. Whyte, MD
Vice President for Continuing Medical Education
Discovery Health Channel
Session IV: Using Evidence to Reshape Healthcare 3:30–5:00
Developing insights into the socioeconomic impact of medical technologies is fundamental to sound policy development and healthcare reform. This final session reviews influences shaping health technology studies, including InHealth’s own grant-making. Panelists will examine the relevance of comparative effectiveness research, the success and limitations of socioeconomic research, and the value of selected research for policymakers, patients, clinicians, payers, and manufacturers.
Ted R. Mannen
Manatt, Phelps & Phillips LLP
Steve E. Phurrough, MD, MPA
Center for Outcomes and Evidence
Agency for Healthcare Research and Quality
Margo Thorning, PhD
Senior Vice President and Chief Economist
American Council for Capital Formation
DATE: Thursday, November 12, 2009
TIME: Registration/Breakfast: 8:30 a.m., Session One: 9:00 a.m.
LOCATION: Hilton Garden Inn, Washington, DC
ACCOMMODATIONS: In conjunction with this event, special group rates are available for accommodations at the Hilton Garden Inn (815 14th St. NW, Washington, DC 20005). The rate for a single room is $269, plus applicable taxes. Individuals may make their reservations by contacting Angela Lopez, reservations supervisor, at 202/521-1602 (Monday through Friday, 8:30 a.m.-5:00 p.m. EDT) or via email@example.com. Remember to identify yourself as an attendee of the InHealth Fifth Anniversary Summit.